Blue light therapy could speed healing of breast abscesses
NCT ID NCT07179003
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 2 study tests whether adding methylene blue photodynamic therapy (MB-PDT) to standard drainage helps breast abscesses heal faster. Fifty adults with breast abscesses will either receive standard drainage alone or drainage plus MB-PDT. The main goal is to see how quickly symptoms like pain and fever go away.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- methylene blue photodynamic therapy (MB-PDT)
- What this could lead to
- If it works, this could offer a faster, more effective way to clear breast abscesses and reduce the need for repeat procedures.
- What could go wrong
- This is a small, early-phase trial with only 50 participants. The added light therapy may not improve outcomes over standard drainage alone and could cause discomfort or skin reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST ABSCESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.